Effect of Digital Combined Decongestive Therapy in Patients With Breast Cancer-related Lymphedema: a Follow-up Study

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

January 10, 2018

Primary Completion Date

January 5, 2024

Study Completion Date

June 20, 2024

Conditions
Breast Cancer-Related Lymphedema
Interventions
BEHAVIORAL

Digital Combined Decongestive Therapy

Participants received digital combined decongestive therapy, which included an initial face-to-face session where skin care and risk reduction training were provided. Self-bandaging and self-manual lymphatic drainage techniques were demonstrated and practiced under supervision. Additionally, decongestive and breathing exercises were taught to both patients and caregivers. Following this, the intensive treatment phase was conducted remotely using electronic communication technologies over a period of 4 weeks to monitor and guide the therapy. After the intensive phase, participants continued with maintenance therapy, which involved the use of compression stockings. The therapy aimed to reduce limb volume and improve symptoms related to breast cancer-related lymphedema.

Trial Locations (1)

Unknown

Bezmialem Vakıf University Hospital, Istanbul

All Listed Sponsors
lead

Bezmialem Vakif University

OTHER

NCT07014657 - Effect of Digital Combined Decongestive Therapy in Patients With Breast Cancer-related Lymphedema: a Follow-up Study | Biotech Hunter | Biotech Hunter